Sweden
· Delayed Price · Currency is SEK CS Medica Statistics
Total Valuation
CS Medica has a market cap or net worth of SEK 87.07 million.
| Market Cap | 87.07M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CS Medica has 13.81 million shares outstanding. The number of shares has decreased by -2.22% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 13.81M |
| Shares Change (YoY) | -2.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 60.02% |
| Owned by Institutions (%) | n/a |
| Float | 5.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.94 |
| PB Ratio | 28.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.27, with a Debt / Equity ratio of 6.76.
| Current Ratio | 0.27 |
| Quick Ratio | 0.14 |
| Debt / Equity | 6.76 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.85 |
Financial Efficiency
Return on equity (ROE) is -154.39% and return on invested capital (ROIC) is -51.88%.
| Return on Equity (ROE) | -154.39% |
| Return on Assets (ROA) | -29.91% |
| Return on Capital (ROIC) | -51.88% |
| Revenue Per Employee | 789,450 |
| Profits Per Employee | -2.08M |
| Employee Count | 9 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +19.04% |
| 50-Day Moving Average | 8.07 |
| 200-Day Moving Average | 7.92 |
| Relative Strength Index (RSI) | 35.89 |
| Average Volume (20 Days) | 83,261 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CS Medica had revenue of SEK 7.11 million and -18.75 million in losses. Loss per share was -1.52.
| Revenue | 7.11M |
| Gross Profit | 2.76M |
| Operating Income | -21.75M |
| Pretax Income | -24.46M |
| Net Income | -18.75M |
| EBITDA | -21.02M |
| EBIT | -21.75M |
| Loss Per Share | -1.52 |
Balance Sheet
The company has 79,107 in cash and 18.73 million in debt, giving a net cash position of -18.65 million or -1.35 per share.
| Cash & Cash Equivalents | 79,107 |
| Total Debt | 18.73M |
| Net Cash | -18.65M |
| Net Cash Per Share | -1.35 |
| Equity (Book Value) | 2.77M |
| Book Value Per Share | 0.22 |
| Working Capital | -20.54M |
Cash Flow
| Operating Cash Flow | -77,394 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.81%, with operating and profit margins of -306.15% and -263.84%.
| Gross Margin | 38.81% |
| Operating Margin | -306.15% |
| Pretax Margin | -344.20% |
| Profit Margin | -263.84% |
| EBITDA Margin | -295.89% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CS Medica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.22% |
| Shareholder Yield | 2.22% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CS Medica has an Altman Z-Score of -0.62. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.62 |
| Piotroski F-Score | n/a |